Fig. 1From: Lipid nanoparticle-based mRNA delivery systems for cancer immunotherapySchematic of the gene delivery process, highlighting pDNA and mRNA pathways. The diagram illustrates the utilization of exogenous mRNA encoding a target antigen, which results in protein translation and peptide presentation through MHC Class I and II molecules. This process activates both cellular and humoral immune responses, ultimately contributing to tumor eliminationBack to article page